Protease-Activated Drug Development
Open Access
- 1 January 2012
- journal article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (2), 156-179
- https://doi.org/10.7150/thno.4068
Abstract
In this extensive review, we elucidate the importance of proteases and their role in drug development in various diseases with an emphasis on cancer. First, key proteases are introduced along with their function in disease progression. Next, we link these proteases as targets for the development of prodrugs and provide clinical examples of protease-activatable prodrugs. Finally, we provide significant design considerations needed for the development of the next generation protease-targeted and protease-activatable prodrugs.Keywords
This publication has 97 references indexed in Scilit:
- Superior therapeutic efficacy of N-l-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drugEuropean Journal of Cancer, 1999
- Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1International Journal of Cancer, 1999
- The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsEuropean Journal of Cancer, 1998
- Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in RatsStroke, 1998
- Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen PromoterPublished by Elsevier BV ,1996
- Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesisJournal of Neurosurgery, 1995
- Enantioselective Release of 5-Fluorouracil from N-(2-Hydroxypropyl)methacrylamide-Based Copolymers via Lysosomal EnzymesBioconjugate Chemistry, 1995
- Activation of the 92 kDa type IV collagenase by tissue kallikreinJournal of Cellular Physiology, 1993
- Mitogenic Response of Osteoblast Cells to Prostate-Specific Antigen Suggests an Activation of Latent TGF-β and a Proteolytic Modulation of Cell Adhesion ReceptorsBiochemical and Biophysical Research Communications, 1993
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990